← Back to all trials
Not Yet Recruiting
NCT07216586
Zynrelef Versus Adductor Canal Block
Conditions: Knee Osteoarthritis, Arthritis Knee
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 120
Sponsor: University of Miami
Location: University of Miami Miami Florida
Summary
To compare postoperative MME consumption 72 hours after TKA in patients receiving intraoperative periarticular HTX-011 (Zynrelef) instillation versus adductor canal block.
Eligibility Criteria
Inclusion Criteria:
* Patients \> 18 years of age
* Patients undergoing primary, unilateral total knee arthroplasty
* Ability to provide informed consent
Exclusion Criteria:
* Individuals under the age of 18
* Pregnant women
* Prisoners
* Adults unable to consent
* American Society of Anesthesiologists Physical Status score greater than 3
* Patients taking any of the following medications before surgery:
* Long-acting opioids within 3 days
* Any opioids taken within 24 hours
* Bupivacaine HCL within 5 days
* Chronic opioid use or patients with known or suspected daily use of opioids for seven or more consecutive days within 6 months before their scheduled surgery
* Illicit drug use determined by social history
* Alcohol abuse determined by a CAGE Substance Abuse Screening Tool Score of at least two or greater
* Patients with a known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to any local anesthetic agent of the amide-type, NSAIDs, or to any of the other components of ZYNRELEF
* Patients with a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients
Source: ClinicalTrials.gov (NCT07216586). StuddyBuddy aggregates publicly available trial information.